| Zacks Company Profile for Bionano Genomics, Inc. (BNGO : NSDQ) |
|
|
| |
| • Company Description |
| BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San Diego, United States.
Number of Employees: 100 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $3.32 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 76,654 shares |
| Shares Outstanding: 3.36 (millions) |
| Market Capitalization: $11.17 (millions) |
| Beta: 2.20 |
| 52 Week High: $41.33 |
| 52 Week Low: $2.68 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-9.54% |
-12.25% |
| 12 Week |
-25.73% |
-35.62% |
| Year To Date |
-80.78% |
-81.84% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
9540 TOWNE CENTRE DRIVE SUITE 100
-
SAN DIEGO,CA 92121
USA |
ph: 858-888-7600
fax: - |
ir@bionano.com |
http://www.bionano.com |
|
|
| |
| • General Corporate Information |
Officers
R. Erik Holmlin - Chief Executive Officer and Director
Mark Adamchak - VP; Accounting
David L. Barker - Director
Albert A. Luderer - Director
Yvonne Linney - Director
|
|
Peer Information
Bionano Genomics, Inc. (CORR.)
Bionano Genomics, Inc. (RSPI)
Bionano Genomics, Inc. (CGXP)
Bionano Genomics, Inc. (BGEN)
Bionano Genomics, Inc. (GTBP)
Bionano Genomics, Inc. (RGRX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 09075F404
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 3.36
Most Recent Split Date: 1.00 (0.02:1)
Beta: 2.20
Market Capitalization: $11.17 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-2.62 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-10.26 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/06/25 |
|
|
|
| |
